Literature DB >> 12358361

Giant-cell tumour of the tendon sheath in the foot and ankle.

C L M H Gibbons1, H A Khwaja, A S Cole, P H Cooke, N A Athanasou.   

Abstract

Giant-cell tumour of the tendon sheath (GCT-TS) is a benign solitary tumour which usually arises in the limbs. It occurs most often in the hand where local recurrence after excision has been reported in up to 45% of cases. It is less common in the foot where the biological behaviour and risk of local recurrence have not been defined. We have studied 17 cases of GCT-TS of the foot and ankle in which treatment was by excision. Fifteen presented as a solitary, painless, slow-growing soft-tissue swelling. One lesion was associated with sensory deficit of a digital nerve and one with pain on walking. Thirteen cases originated from the periarticular tendon-sheath complex of the small joints of the toes and four from the capsule or long tendons of the ankle. A correct preoperative diagnosis was made in only three cases. MRI proved to be the most useful preoperative investigation as GCT-TS has a characteristic appearance which allows planned local excision to be carried out. None of the patients with histologically confirmed GCT-TS required further surgery. There was no local recurrence in 15 patients who were available for follow-up at a mean of 85 months.

Entities:  

Mesh:

Year:  2002        PMID: 12358361     DOI: 10.1302/0301-620x.84b7.13115

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  16 in total

Review 1.  Imaging of giant cell tumour of the tendon sheath.

Authors:  J M C Wan; N Magarelli; W C G Peh; G Guglielmi; T W H Shek
Journal:  Radiol Med       Date:  2010-02       Impact factor: 3.469

2.  Giant cell tumor of the tendon sheath originating from the ankle capsule: A case report and literature review.

Authors:  Y U Chen; Xiu-Chun Yu; Song-Feng Xu; Bing Wang
Journal:  Oncol Lett       Date:  2016-03-24       Impact factor: 2.967

3.  Giant cell tumor of the tendon sheath mimicking a primary intramedullary metatarsal tumor.

Authors:  Joshua E Lantos; Meera Hameed; John H Healey; Sinchun Hwang
Journal:  Skeletal Radiol       Date:  2012-11-10       Impact factor: 2.199

4.  Tenosynovial Giant Cell Tumors in Children: A Similar Entity Compared With Adults.

Authors:  Monique J L Mastboom; Floortje G M Verspoor; Daniël Uittenbogaard; Gerard R Schaap; Paul C Jutte; H W Bart Schreuder; Michiel A J van de Sande
Journal:  Clin Orthop Relat Res       Date:  2018-09       Impact factor: 4.176

5.  Diffuse-type giant cell tumor of the tendon sheath in the temporal region incidentally diagnosed due to a temporal tumor: A report of two cases and review of the literature.

Authors:  Jia Ruo Qin; Long Jin; Kong Liang Li; Shan Shan Zhang; Jie Kong; Hong Yu Yang
Journal:  Oncol Lett       Date:  2015-05-28       Impact factor: 2.967

6.  Giant cell tumour of tendon sheath with bone invasion in extremities: analysis of clinical and imaging findings.

Authors:  Cheng-Sheng Wang; Qing Duan; Yun-Jing Xue; Xin-Ming Huang; Li-Li Wang; Zhi-Yong Chen; Jian-Hua Chen; Bin Sun
Journal:  Radiol Med       Date:  2015-02-20       Impact factor: 3.469

7.  Pigmented villonodular synovitis great toe.

Authors:  Ajay Lunawat; Dharmendra Mehta; Sanjay Datey; N Charles; S Khandelwal; B Shaam; J K Yadav
Journal:  Indian J Surg       Date:  2012-07-31       Impact factor: 0.656

8.  Tenosynovial giant cell tumors as accidental findings after episodes of distortion of the ankle: two case reports.

Authors:  Christian Illian; Horst-Rainer Kortmann; Hans Otto Künstler; Ludger W Poll; Markus Schofer
Journal:  J Med Case Rep       Date:  2009-12-15

Review 9.  Imaging appearances of soft-tissue tumors of the pediatric foot: review of a 15-year experience at a tertiary pediatric hospital.

Authors:  Pablo Caro-Domínguez; Oscar M Navarro
Journal:  Pediatr Radiol       Date:  2017-10-26

10.  Diffuse Type Tenosynovial Giant Cell Tumor of the Ankle.

Authors:  Jing-Jing Zhao; Ming Xie; Ruo-Kun Huang; Kai Xiao
Journal:  Chin Med J (Engl)       Date:  2016-04-05       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.